LIPO (Lipella Pharmaceuticals) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 02, 2026)


LIPO Lipella Pharmaceuticals Inc LIPO
35 GF Score
Price $0.13
GF Value $8.68
Valuation Possible Value Trap
! 1 Warning Sign
View Full Analysis

What is Lipella Pharmaceuticals Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Lipella Pharmaceuticals's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

LIPO vs IOBTQ, WINT, CYTOF: Margin of Safety % (DCF Dividends Based) Comparison

For the Biotechnology subindustry, Lipella Pharmaceuticals's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lipella Pharmaceuticals Margin of Safety % (DCF Dividends Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lipella Pharmaceuticals's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Lipella Pharmaceuticals's Margin of Safety % (DCF Dividends Based) falls into.


LIPO
35GF Score
Lipella Pharmaceuticals Inc LIPO
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lipella Pharmaceuticals (LIPO) Overvalued in 2026?

Based on GuruFocus' analysis, Lipella Pharmaceuticals stock appears to be undervalued. The current stock price of $0.13 is trading 98.5% below its estimated GF Value™ of $8.68. GuruFocus considers Lipella Pharmaceuticals to be Possible Value Trap.

Key valuation signals for LIPO:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: $8.68 vs. price of $0.13 (98.5% below fair value)
  • GF Score™: 35/100 with 1 warning sign

No single metric tells the full story. See the LIPO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lipella Pharmaceuticals Business Description

Address 7800 Susquehanna Street, Suite 505, Pittsburgh, PA, USA, 15208
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410, which can be helpful in the treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
35GF Score

Get the complete analysis for LIPO

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13
Price
$8.68
GF Value